Kukje Pharma Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kukje Pharma Co Ltd with three other
companies in this sector in South Korea:
Hyundai Pharmaceutical Company Limited
sales of 130.48 billion Korean Won [US$116.00 million]
of which 88%
Daehwa Pharmaceutical Company Limited
(122.20 billion Korean Won [US$108.64 million]
of which 70%
was Medicine Mafufacture), and
Reyon Pharmaceutical Co Ltd
(126.25 billion Korean Won [US$112.24 million]
Kukje Pharma Co Ltd reported sales of 123.31 billion Korean Won (US$109.62 million)
December of 2017.
increase of 2.2%
versus 2016, when the company's sales were 120.68 billion Korean Won.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Kukje Pharma Co Ltd had sales
of 126.77 billion Korean Won.
Sales of Cosmetics saw an increase
that was more than double the company's growth rate: sales were up
767.2% in 2017, from
991.59 million Korean Won to 8.60 billion Korean Won.
Not all segments of Kukje Pharma Co Ltd experienced an increase in sales in 2017:
sales of Other Segment fell 82.1% to 1.02 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).
Kukje Pharma Co Ltd also experienced decreases in sales in
Pharmaceutical (down 0.3% to 113.69 billion Korean Won)